Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceWomen's health

D-Chiro-Inositol

D-chiro-inositol is the less-studied inositol isomer, and the enthusiasm rests largely on one small 1999 trial that later work failed to reproduce. Myo-inositol has the better evidence base, and high-dose D-chiro-inositol may actually be counterproductive for ovarian function.

What the science says

  • Ovulation benefit in PCOS was not reproduced Limited evidence

    A widely cited 1999 trial reported that 1,200 mg/day D-chiro-inositol improved ovulation and insulin sensitivity in women with PCOS, but a Cochrane review of insulin-sensitising drugs concluded the evidence for D-chiro-inositol on live birth, pregnancy and ovulation is of very low quality and insufficient to support use. Subsequent trials by other groups have not replicated the original effect size.

  • Myo-inositol, not D-chiro-inositol, carries the guideline evidence Moderate evidence

    The systematic review and meta-analysis informing the 2023 International PCOS Guidelines found inositol supplementation — dominated by myo-inositol at 2-4 g/day — improved fasting insulin and HOMA-IR modestly, with low-certainty evidence for reproductive outcomes. The guidelines stop short of recommending it over metformin, and D-chiro-inositol specifically was too sparsely studied to grade separately.

  • The 40:1 ratio rationale is mechanistic, not outcome-proven Limited evidence

    Popular products use a 40:1 myo- to D-chiro-inositol ratio to mimic reported plasma physiology, typically 2,000 mg myo plus 50 mg D-chiro twice daily. No adequately powered trial has shown a 40:1 blend beats myo-inositol alone; the ratio is a plausible hypothesis that has been marketed as an established fact.

  • High doses may impair oocyte quality Limited evidence

    The so-called D-chiro-inositol paradox describes observations that ovarian tissue in PCOS may already over-convert myo- to D-chiro-inositol, and small studies suggest escalating D-chiro-inositol doses of 600 mg/day and above were associated with worse oocyte and embryo quality in IVF settings. This is preliminary, but it is a concrete reason not to assume more is better.

Dosage & safety

Studied doseStudies of standalone D-chiro-inositol used 600-1,200 mg/day, usually split twice daily. Combination products supply myo-inositol 4,000 mg plus D-chiro-inositol 100 mg per day (the 40:1 ratio), typically as two 2,000 mg/50 mg doses. Trials run 12-24 weeks before assessing cycle regularity or metabolic markers. If choosing one, myo-inositol 2,000 mg twice daily is the better-supported option.
SafetyGenerally well tolerated; GI upset, nausea, flatulence and headache are the main complaints, mostly above 4 g/day of total inositol. Can add to the glucose-lowering effect of metformin, insulin or sulfonylureas. Data in pregnancy are limited despite frequent use for gestational diabetes prevention — discuss with an obstetric clinician rather than self-prescribing. It is not a fertility treatment on its own and does not replace evaluation for PCOS, thyroid disease or other causes of irregular cycles. Not banned in sport.

Scientific references

Where to buy

Swanson Vitamins, Chirositol® D-Chiro-Inositol, 85 mg, 60 Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Women's health